Nikos C Papandreou
Overview
Explore the profile of Nikos C Papandreou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zacharogianni M, Papandreou N, Marinakis N, Tilemis F, Traeger-Synodinos J, Palioura S
Am J Ophthalmol
. 2025 Mar;
PMID: 40049267
Purpose: To describe a novel pathogenic TGFBI variant identified in a Greek family and investigate its structural impact on the TGFBI protein, focusing on clinical significance and genotype-phenotype correlations. Design:...
2.
Theodoropoulou M, Vraila K, Papandreou N, Nasi G, Iconomidou V
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858424
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by extracellular amyloid plaques, predominantly consisting of amyloid- (A) peptides. The oligomeric form of A is acknowledged as the most neurotoxic,...
3.
Gioran A, Paikopoulos Y, Panagiotidou E, Rizou A, Nasi G, Dimaki V, et al.
Antioxidants (Basel)
. 2024 Mar;
13(3).
PMID: 38539796
Alzheimer's disease (AD) is the most common form of dementia. Given the link between oxidative stress and AD, many studies focus on the identification of natural antioxidants against AD. Although...
4.
Rizou A, Nasi G, Paikopoulos Y, Bezantakou D, Vraila K, Spatharas P, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239029
Today, Alzheimer's disease (AD)-the most common neurodegenerative disorder, which affects 50 million people-remains incurable. Several studies suggest that one of the main pathological hallmarks of AD is the accumulation of...
5.
Nasi G, Georgakopoulou K, Theodoropoulou M, Papandreou N, Chrysina E, Tsiolaki P, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986878
Type I fimbriae are the main adhesive organelles of uropathogenic (UPEC), consisting of four different subunits. Their component with the most important role in establishing bacterial infections is the FimH...
6.
Vassilaki N, Papadimitriou K, Ioannidis A, Papandreou N, Milona R, Iconomidou V, et al.
Microorganisms
. 2022 Jul;
10(7).
PMID: 35889149
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus that belongs to the family, emerged in December 2019, causing the COVID-19 pandemic in March 2020. Unlike previous SARS and...
7.
Spatharas P, Nasi G, Tsiolaki P, Theodoropoulou M, Papandreou N, Hoenger A, et al.
Biochim Biophys Acta Mol Basis Dis
. 2022 Mar;
1868(7):166384.
PMID: 35292360
Clusterin is a heterodimeric glycoprotein (α- and β-chain), which has been described as an extracellular molecular chaperone. In humans, clusterin is an amyloid-associated protein, co-localizing with fibrillar deposits in several...
8.
Giannopoulou A, Velentzas A, Anagnostopoulos A, Agalou A, Papandreou N, Katarachia S, et al.
Cancers (Basel)
. 2021 Apr;
13(9).
PMID: 33922182
Melanoma is classified among the most notoriously aggressive human cancers. Despite the recent progress, due to its propensity for metastasis and resistance to therapy, novel biomarkers and oncogenic molecular drivers...
9.
Galanis K, Nastou K, Papandreou N, Petichakis G, Pigis D, Iconomidou V
Int J Mol Sci
. 2021 Apr;
22(6).
PMID: 33809918
Linear B-cell epitope prediction research has received a steadily growing interest ever since the first method was developed in 1981. B-cell epitope identification with the help of an accurate prediction...
10.
Nastou K, Karataraki E, Papandreou N, Rerra A, Grimanelli V, Maglogiannis I, et al.
Adv Exp Med Biol
. 2020 May;
1194:359-371.
PMID: 32468552
Monoclonal antibodies (mAbs) constitute a promising class of therapeutics, since ca. 25% of all biotech drugs in development are mAbs. Even though their therapeutic value is now well established, human-...